Rituximab for the treatment of type II mixed cryoglobulinemia.
Zaja
F
F
Russo
D
D
Fuga
G
G
Patriarca
F
F
Ermacora
A
A
Baccarani
M
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D003449:Cryoglobulinemia / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab